Pharmalicensing brings you advice, commentary and analysis from industry experts.
Marcus Brady is Director of Corporate Development at Neurochem Inc. Lawrence Goldman is Web Marketing Manager at Decisioneering, Inc.
Marcus Brady, Director, Corporate Development at Neurochem
Inc. Mr. Brady oversees Neurochem's corporate alliance
initiatives with synergistic, fully integrated drug firms.
Drawing upon an extensive background in technology
licensing, venture capital, contract negotiation,
intellectual
property protection, research and development, and
corporation alliance formation, he manages and expedites
the commercialization of Neurochem technologies. Prior to joining Neurochem in August 1994, he led the
pharmaceutical and medical business development and
marketing activities of the National Research Council,
Canada's largest research and development organization.
In that role, he established corporate relationships,
collaborative research ventures and licensing agreements
with large and small biotechnology and pharmaceutical
companies Mr. Brady holds an M.Sc. in Medical Physiology from the
Health Sciences Centre of the University of Ottawa,
Ontario, Canada, and a B.Sc. in Biochemistry from McGill
University, Montreal, Quebec, Canada. He is an
executive member of the Canadian Health Care Licensing
Association. Lawrence Goldman, Web Marketing Manager, Decisioneering,
Inc. Mr. Goldman currently directs Decisioneering's Web site
development and Internet marketing strategies. During
his tenure at the company, he has held positions as program
manager, software trainer, and advanced technical
support technician. Prior to 1997, he served as a technician
in the mining software industry and as an exploration
mining geologist. Mr. Goldman holds a M.S. in Geology from
the University of Cincinnati, Cincinnati, Ohio, and B.A
from Cornell University, Ithaca, New York.